AN UNBIASED VIEW OF AZELAPRAG BIOAGE

The biotech sought to bear this system out in STRIDES, a mid-stage, randomized, double-blinded and placebo-managed demo that evaluated the efficacy and safety of azelaprag—with and with no Eli Lilly’s blockbuster incretin therapy tirzepatide—in a lot more than two hundred people today with being overweight.To complicate this further, tirzepat